Jones Financial Companies
INAB icon

Jones Financial Companies’s IN8bio INAB Stock Holding History

Jones Financial Companies’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Hold
768
– – ﹤0.01% 4599
2026
Q1 		$1.08K Sell
768
-460
-37% -$890 ﹤0.01% 4330
2025
Q4 		$2.87K Buy
+1,228
New +$2.33K ﹤0.01% 3714

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jones Financial Companies's INAB Position: Q2 2026 in Review

Jones Financial Companies held its IN8bio (INAB) position steady in Q2 2026 at 768 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4599.

Jones Financial Companies first reported a position in INAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.87K in Q4 2025. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

  • Jones Financial Companies held 768 shares of IN8bio worth $1.04K as of Q2 2026.
  • Jones Financial Companies left its IN8bio share count unchanged in Q2 2026.
  • IN8bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4599 holding.
  • Jones Financial Companies first reported a position in IN8bio in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's IN8bio position peaked at $2.87K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.